Affiliation:
1. Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich
2. Clinica Hildebrand Centro di riabilitazione Brissago
Abstract
Abstract
Background
Unsupervised robot-assisted rehabilitation is a promising approach to increase the dose of therapy after stroke, which may help promote sensorimotor recovery without requiring significant additional resources and manpower. However, the unsupervised use of robotic technologies is not yet a standard, as rehabilitation robots often show low usability or are considered unsafe to be used by patients independently. In this paper we explore the feasibility of unsupervised therapy with an upper limb rehabilitation robot in a clinical setting, evaluate the effect on the overall therapy dose, and assess user experience during unsupervised use of the robot and its usability.
Methods
Subacute stroke patients underwent a four-week protocol composed of daily 45 minutes-sessions of robot-assisted therapy. The first week consisted of supervised therapy, where a therapist explained how to interact with the device. The second week was minimally supervised, i.e., the therapist was present but intervened only if needed. After this phase, if participants learnt how to use the device, they proceeded to two weeks of fully unsupervised training. Feasibility, dose of robot-assisted therapy achieved during unsupervised use, user experience, and usability of the device were the primary outcome measures. Questionnaires to evaluate usability and user experience were performed after the minimally supervised week and at the end of the study, to evaluate the impact of therapists’ absence.
Results
Unsupervised robot-assisted therapy was found to be feasible, as 12 out of the 13 recruited participants could progress to unsupervised training. During the two weeks of unsupervised therapy participants on average performed an additional 360 minutes of robot-assisted rehabilitation. Participants were satisfied with the device usability (mean System Usability Scale scores > 79), and no adverse events or device deficiencies occurred.
Conclusions
We demonstrated that unsupervised robot-assisted therapy in a clinical setting with an actuated device for the upper limb was feasible and can lead to a meaningful increase in therapy dose.
Trial registration
Registered on 13.05.2020 on clinicaltrials.gov (NCT04388891).
Publisher
Research Square Platform LLC
Reference46 articles.
1. Lawrence ES, Coshall C, Dundas R, Stewart J, Rudd AG, Howard R et al. Estimates of the Prevalence of Acute Stroke Impairments and Disability in a Multiethnic Population. Stroke [Internet]. 2001 Jun [cited 2020 Jul 21];32(6):1279–84. Available from: https://www.ahajournals.org/doi/10.1161/01.STR.32.6.1279.
2. Tollár J, Nagy F, Csutorás B, Prontvai N, Nagy Z, Török K et al. High Frequency and Intensity Rehabilitation in 641 Subacute Ischemic Stroke Patients. Arch Phys Med Rehabil [Internet]. 2021 Jan 1 [cited 2021 Jun 24];102(1):9–18. Available from: https://pubmed.ncbi.nlm.nih.gov/32861668/.
3. Comparison of robotics, functional electrical stimulation, and motor learning methods for treatment of persistent upper extremity dysfunction after stroke: A randomized controlled trial;McCabe J;Arch Phys Med Rehabil,2015
4. Intensive upper limb neurorehabilitation in chronic stroke: Outcomes from the Queen Square programme;Ward NS;J Neurol Neurosurg Psychiatry,2019
5. Jesus TS, Landry MD, Dussault G, Fronteira I. Human resources for health (and rehabilitation): Six Rehab-Workforce Challenges for the century. Hum Resour Health [Internet]. 2017 Jan 23 [cited 2022 Feb 2];15(1). Available from: /pmc/articles/PMC5259954/.